Erin McEvoy

According to the Division of Cannabis Control, medical marijuana sales exceeded $2.2 billion and recreational cannabis generated over $785 million since legalization.

Clinical and in vitro analysis shows THC may impair female fertility, distrupting oocyte development and affecting IVF outcomes.

The FY26 CJS Appropriations Act includes Section 607, barring cannabis rescheduling. Advocates warn the Act threatens medical cannabis protections.

Our top five cannabis and hemp news this week: Nebraska’s medical cannabis battle, rescheduling debate, Thailand policy shifts, new medical cannabis research, and pricing trends.

This month’s Healer webinar, led by Dustin Sulak, DO, explores new medical cannabis research including potential benefits for cancer, wound healing, ALS, Alzheimer’s, and terpenes like alpha-pinene.

In this interview, Steve Allin, director of the International Hemp Building Association shares insights on the versatility and benefits of hemp as a crop and as a material used in construction.

An examination of survey data finds state cannabis laws strongly shape delta-8-THC use, with highest rates in prohibition states.

Citing risks to children, health, and public safety, nine Congress members sent a letter to Attorney General Pam Bondi and President Donald Trump, opposing the rescheduling of cannabis.

Here, we bring you our top five recent articles covering federal hemp ban, an interview with Reginald Gaudino, PhD, the reintroduced MORE Act, Delaware cannabis sales and rezoning, and restricting intoxicating hemp-derived cannabinoids.

Recent research highlights the potential of cannabinoids as alternative treatments for atopic dermatitis, showcasing their anti-inflammatory and antibacterial properties.

The organization voiced its support of Texas and other states restricting synthetic hemp cannabinoids, urging science-based regulation to protect consumers, businesses, and public safety.

As more studies are being conducted on multiple parts of the cannabis plant, this study tested the root samples against four cancer cell lines, finding evidence of antiproliferation effects.

Hemp has the potential to be a sustainable resource for textiles and building materials, but it still has to overcome the stigma and regulatory hurdles that challenge its widespread adoption.

Here, we bring you our top five recent articles covering a $3.6 million grant for Minnesota’s cannabis industry, kidney disease and cannabis use, banking reform, flavoalkaloids in leaves, and CBD and liver enzyme levels.

Two organizations with opposing views recently prepared letters to the Trump Administration on the anticipated action regarding cannabis reclassification.

In collaboration with the California Department of Cannabis Control (DCC), the new feature is anticipated to increase direct access to recall information.

Using an optimized analytical method for this research, the phenolics of cannabis were tested resulting in new findings.

The FDA-funded study found that CBD was linked to elevated liver enzymes in some healthy adults, underscoring need for further safety research.

Here, we bring you our top four recent articles covering research on cannabinoids and sleep, why enrolled patients turn to illegal cannabis, using spent hemp biomass as livestock feed, and testing cannabinoids on breath after ingesting edibles.

The researchers measured the amount of THC and other cannabinoids on participants’ breaths, with results demonstrating an increase in THC concentration from baseline samples.

The exploratory analysis suggest that lower costs and reliable supply could affect reliance on illegal medical cannabis in Utah.

The study tracks how THC and CBD levels in cow milk, plasma, and fat tissue change during hemp feed intake and withdrawal periods.

In the second part of this webinar coverage, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.

Here, we bring you our top five recent articles covering National CBD Day 2025, medical cannabis patients’ workers’ compensation, Trump looking into cannabis rescheduling, research studies on cannabis for sleep, and a clinical trial for CBD and insomnia.

In this month’s webinar, Dustin Sulak, DO, explains recent research and studies on cannabinoids and their effect on sleep and conditions affecting sleep.

The referral-based partnership aims to provide cannabis businesses with comprehensive solutions that merge compliance, payroll, insurance, and risk management services.

President Trump recently stated interest in considering the reclassification of cannabis with an update on the decision anticipated within the coming weeks. Industry stakeholders, including CST blog author Kim Anzarut, weigh in.

House Bill 1766 proposes that qualifying employees receive up to $250 monthly and $3000 annually for approved medical cannabis purchases.

Here, we bring you our top five recent articles covering multiple stories on adult-use cannabis sales in Delaware, the top compliance issues in 2025, and research on how medical cannabis affects healthcare utilization by chronic pain patients.

Analysis of two coffee products revealed 70–80% less CBD in the brewed coffee than what was indicated on the label.